Two back-to-back "Nature Immunology" reveal the details of chronically infected patients "exhausted" immune cells
Guangzhou Health Institute published an article in Nature: A new mechanism for regulating pluripotent cell-somatic cell transition
The first company in the world to use stem cells to treat hair loss, the US startup received US$15 million from AbbVie Capital and others
Express Sword refers to many diseases such as diabetes, NASH, heart failure, etc. Xin Rui aims to improve cell metabolism
Dr. Hongbo Chi Nature published an article: CRISPR-Cas9 technology analyzes the selective regulation of key immune cells
Sci Adv: Cancer cells may protect themselves to survive through the process of "self-eating"
"Cell" How do gut bacteria shape the "circadian rhythm" even in a dark environment
Southern Medical University Cell publication: The important role of lysosomes in the multidirectional differentiation of mesenchymal stem cells
Bispecific antibody + new stem cell transplantation Janssen collaborates to develop a combination therapy for blood cancer
iFLT-PET/CT is an early and superior predictor of progression-free survival after chemotherapy and immunotherapy for diffuse large B-cell lymphoma
Amgen's US$2.5 billion acquisition of Teneobio: Acquired dual/multispecific antibody technology platform + new T cell adapter platform!
A new mechanism for plant regulation of endoplasmic reticulum stress-induced cell death revealed
regulatory mechanism of long non-coding RNA on cell nucleolar structure and RNA polymerase I transcription
Cell Sub-Journal: Remember more by taking a break
The Li Yulong laboratory of the School of Life Sciences discovered a new transporter located in synaptic vesicles
Eur J Cancer: Paclitaxel is significantly better than docetaxel in fluoropyrimidine and platinum refractory esophageal squamous cell carcinoma!
Br J Cancer: Aspirin enhances the efficacy of cisplatin in the treatment of esophageal squamous cell carcinoma
Vietnam Vinh Hoan invests in Singapore Cell Meat Project
J Clin Oncol: Donor-derived CD7 chimeric antigen receptor T cells for the treatment of acute T lymphocytic leukemia can be expected in the future!
Cancers: Markers and gene sets predicting the sustained response of Pembrolizumab in patients with non-small cell lung cancer